TAMARA A FAVORITO
CIK 1288232 · CFO, Secretary, Treasurer · last filed 2026-02-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$49.3K
Companies
7
Total Filings
33
Lifetime Open-Market Net
$28.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARTL | Director | — | $1.36 | — | $0 | 4 | 2026-02-02 |
| ZVRA | Director | 3,894 | $12.65 | $49.3K | $27.2K | 6 | 2025-09-16 |
| ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Director | — | $0.01 | — | $0 | 6 | 2024-03-01 |
| TuHURA Biosciences, Inc./NV (KTRA) Delisted | Director | — | $7.54 | — | $0 | 4 | 2023-09-01 |
| ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Director | 200 | $5.81 | $1.2K | $974 | 2 | 2022-06-30 |
| Viridian Therapeutics, Inc.\DE (SGNL) Delisted | CFO, Secretary, Treasurer | 66,505 | — | — | $0 | 6 | 2016-11-02 |
| MMRGlobal, Inc. (FVRL) Delisted | CFO | 45,640 | — | — | $0 | 3 | 2008-04-28 |
Recent Filings · Page 3 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-03 | TuHURA Biosciences, Inc./NV (KTRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-09 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-02 | Viridian Therapeutics, Inc.\DE (SGNL) Delisted | Mixed | +79,453 | -$24.0K | EDGAR |
| 2016-08-10 | Viridian Therapeutics, Inc.\DE (SGNL) Delisted | Mixed | +12,516 | -$5.1K | EDGAR |
| 2016-05-19 | Viridian Therapeutics, Inc.\DE (SGNL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-14 | Viridian Therapeutics, Inc.\DE (SGNL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-05 | Viridian Therapeutics, Inc.\DE (SGNL) Delisted | Mixed | +14,478 | -$13.3K | EDGAR |
| 2014-08-04 | Viridian Therapeutics, Inc.\DE (SGNL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-29 | — | Grant (A) | — | $0 | |
| 2008-12-18 | — | Sell (S) | −5,000 | -$92 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.